510(k) device
Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing
Coagusense, Inc. · Test, Time, Prothrombin (GJS, Class II) · First FDA decision Feb 21, 2019, newest Oct 5, 2022Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Coag-Sense"
MAUDE reports
9
Brand "Coag-Sense", since 2015
PubMed studies
3
Mentioning "Coag-Sense"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K212779 · Decided Oct 5, 2022 · 399 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
K183255 · Decided Feb 21, 2019 · 92 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Coag-Sense", any status and sponsor, newest update first.
No registered device study names "Coag-Sense".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Coag-Sense", and for the whole product code for context.
This brand
9 reports: 2 malfunction, 7 injury, 0 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
3007507465-2026-00002 · Received Mar 18, 2026 · Event dated Jul 7, 2025
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Output Problem
Patient problem as coded: Coagulation Disorder
3007507465-2026-00003 · Received Mar 18, 2026 · Event dated Oct 31, 2025
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings; High Test Results; Therapeutic or Diagnostic Output Failure
Patient problem as coded: Coagulation Disorder; Retinal Injury; Loss of Vision; Thrombosis/Thrombus
3007507465-2026-00001 · Received Mar 9, 2026 · Event dated Jul 7, 2025
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Ischemia Stroke
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Mckesson Medical-Surgical Inc. Corporate Office
Z-1583-2022 · Started May 25, 2022 · Posted by FDA Aug 26, 2022
Reason given: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Cause as FDA categorized it: Environmental control · Device type: Test, Time, Prothrombin (GJS)
Published research
The most relevant PubMed records for "Coag-Sense"[tiab]. The summary above synthesizes these.
- CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation.
McBane RD, O'Connor C, Lutz J, et al. · Mayo Clin Proc · 2024Multicenter Study, Validation Study
- Comparison of two point-of-care international normalized ratio devices and laboratory method.
Vazquez SR, Fleming RP, Johnson SA · Blood Coagul Fibrinolysis · 2017
- Evaluating a Rapid Field Assessment System for Anticoagulant Rodenticide Exposure of Raptors.
Dickson AJ, Belthoff JR, Mitchell KA, et al. · Arch Environ Contam Toxicol · 2020
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- CoaguChek XS Pro SystemRoche Diagnostics · 510(k) 2018
- Hemosil Recombiplastin 2G (8 Ml Vial)Instrumentation Laboratory CO · 510(k) 2014
- Coaguchek Xs SystemRoche Diagnostics Corp. · 510(k) 2007
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
- STA- NeoPTimalDiagnostica Stago S.A.S · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.